Insiders Aditxt, Inc.

Equities

ADTX

US0070256047

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
2.01 ^USD	0.00%		-2.90%	-69.68%

May. 03	Aditxt, Inc. announced that it expects to receive $4.2 million in funding	CI
May. 02	Aditxt, Inc. announced that it expects to receive $150 million in funding	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aditxt, Inc. Announces Board Changes	Nov. 09	CI
Aditxt, Inc. Announces Resignation of Matthew Shatzkes as Chief Legal Officer, General Counsel and Corporate Secretary	23-07-27	CI
Aditxt, Inc. Appoints Maureen Connolly as Chief Content and Engagement Officer	23-03-08	CI
Aditxt Forms New US Unit to Focus on Immune Modulation Therapies	23-01-03	MT
Aditxt, Inc. Announces Board Changes	21-12-28	CI
Aditxt : Names Corinne Pankovcin President, Thomas Farley CFO	21-09-27	MT
Aditxt, Inc. Appoints Corinne Pankovcin as President	21-09-27	CI
Aditxt Appoints Thomas J. Farley as Chief Financial Officer	21-09-27	CI
Aditx Therapeutics, Inc Announces the Appointment of Dr. Lauren Chung to its Board of Directors	21-06-18	CI
ADiTx Therapeutics, Inc. Appoints Sunny Uberoi as its First Chief Communications Officer	21-04-13	CI
ADiTx Therapeutics : Collection Sites, LLC Named AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring through its Mobile Testing Centers	21-04-01	PR
ADiTx Therapeutics : Collection Sites, LLC Named AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring Through Its Mobile Testing Centres	21-04-01	AQ
Aditx Therapeutics, Inc. Appoints Thomas J. Farley as Principal Accounting Officer	21-03-24	CI
ADiTx Therapeutics, Inc. Appoints Dolly B. Tyan as Senior Vice President of Clinical Development - Transplantation	21-01-29	CI
Aditx Therapeutics, Inc. Appoints Anthony Voorhies as Head of Business Development for AditxtScore	20-11-20	CI
ADiTx Therapeutics : Former Chief Medical Officer and Assistant Secretary for Health Affairs of the U.S. Department of Homeland Security, Dr. Jeffrey Runge, Appointed to Aditxt Board of Directors	20-10-01	AQ
Former Chief Medical Officer and Assistant Secretary for Health Affairs of the U.S. Department of Homeland Security, Dr. Jeffrey Runge, Appointed to Aditxt Board of Directors	20-10-01	GL
Namvar Kiaie Joinsaditx Therapeutics, Inc.'s Board of Directors	20-08-25	CI
ADiTx Therapeutics, Inc. Appoints Joachim-Friedrich Kapp, as Vice President of Clinical Development, Autoimmunity	20-08-14	CI
Rosland McLeod Resigns as Member of the Board of Directors of Aditx Therapeutics Inc	20-08-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Aditxt, Inc.

Equities

ADTX

US0070256047

Insiders

Filters